国金300指数增强A
Search documents
机构风向标 | 钜泉科技(688391)2025年三季度已披露前十大机构持股比例合计下跌2.20个百分点
Xin Lang Cai Jing· 2025-10-31 02:54
Core Insights - Jiuquan Technology (688391.SH) reported its Q3 2025 results on October 31, 2025, highlighting significant institutional investor activity [1] Institutional Holdings - As of October 30, 2025, seven institutional investors disclosed holdings in Jiuquan Technology A-shares, totaling 53.9583 million shares, which represents 46.85% of the company's total equity [1] - The institutional investor group includes Jiuquan Technology (Hong Kong) Co., Ltd., Dongsheng Investment Co., Ltd., GaoHua Investment Co., Ltd., Juchuang Integrated Circuit Design Co., Ltd., Wanjun Industrial Co., Ltd., Guojin 300 Index Enhanced A, and China Merchants National Certificate 2000 Index Enhanced A [1] - Compared to the previous quarter, the total institutional holding percentage decreased by 2.20 percentage points [1] Public Fund Activity - In this reporting period, two public funds increased their holdings compared to the previous period, namely Guojin 300 Index Enhanced A and China Merchants National Certificate 2000 Index Enhanced A, with a slight increase in holding percentage [1] - A total of 65 public funds that were previously disclosed did not report their holdings this quarter, including notable funds such as Baodao Growth Zhihang Stock A, Baodao Shanghai Stock Exchange Science and Technology Innovation Board Comprehensive Index Enhanced A, and others [1]
机构风向标 | 方大集团(000055)2025年三季度已披露持仓机构仅2家
Xin Lang Cai Jing· 2025-10-29 02:39
Core Viewpoint - Fangda Group (000055.SZ) reported its Q3 2025 results, highlighting an increase in institutional investor holdings and the presence of several public funds [1] Institutional Holdings - As of October 28, 2025, two institutional investors disclosed holdings in Fangda Group A-shares, totaling 123 million shares, which represents 11.45% of the company's total equity [1] - The institutional holding ratio increased by 0.30 percentage points compared to the previous quarter [1] Public Fund Participation - In this reporting period, 12 public funds were disclosed, which were not reported in the previous quarter [1] - Notable public funds include Guojin 300 Index Enhanced A, Huibaichuan Yuanhang Mixed A, Penghua Quantitative Pioneer Mixed, Huquan Strategy Preferred Mixed A, and Hongde Dividend Preferred Mixed (LOF) A [1]
机构风向标 | 鹭燕医药(002788)2025年二季度已披露持仓机构仅3家
Sou Hu Cai Jing· 2025-08-26 00:29
Core Viewpoint - Luyuan Pharmaceutical (002788.SZ) reported its semi-annual results for 2025, highlighting the current institutional ownership and changes in shareholding among various investor categories [1] Institutional Ownership - As of August 25, 2025, three institutional investors disclosed holdings in Luyuan Pharmaceutical A-shares, totaling 144 million shares, which represents 37.02% of the company's total share capital [1] - The institutional ownership decreased by 0.46 percentage points compared to the previous quarter [1] Public Fund and Social Security Fund - Two public funds were disclosed this period, including Guojin 300 Index Enhanced A and Minsheng Jiayin Guozheng 2000 Index Enhanced A, which were not reported in the previous quarter [1] - One social security fund was disclosed, namely the招商基金管理有限公司-社保基金1903组合, which was also not reported in the previous quarter [1] Foreign Investment - One new foreign institutional investor was disclosed this period, BARCLAYS BANK PLC, which was not present in the previous quarter [1]
机构风向标 | 丰原药业(000153)2025年二季度已披露持仓机构仅7家
Xin Lang Cai Jing· 2025-08-22 02:16
Core Viewpoint - Fengyuan Pharmaceutical (000153.SZ) released its semi-annual report for 2025, indicating a total institutional holding of 141 million shares, accounting for 30.39% of the company's total equity, with a slight decrease of 0.36 percentage points from the previous quarter [1] Institutional Holdings - As of August 21, 2025, seven institutional investors disclosed their holdings in Fengyuan Pharmaceutical, with a combined shareholding of 141 million shares [1] - The institutional investors include Anhui Wuwei Pharmaceutical Factory, Bengbu Tushan Enterprise Management Co., Ltd., Ma'anshan Fengyuan Enterprise Management Co., Ltd., Anhui Fengyuan Group Co., Ltd., Great Wall Guorong Investment Management Co., Ltd., BARCLAYS BANK PLC, and Guojin 300 Index Enhanced A [1] - The total institutional holding percentage decreased by 0.36 percentage points compared to the previous quarter [1] Public Fund and Foreign Investment - One new public fund disclosed its holdings this period, namely Guojin 300 Index Enhanced A [1] - Two public funds that were previously disclosed did not report this quarter, including Guojin CSI A500 Index Enhanced A and Dongxing Lianzhong One-Year Holding Period Mixed A [1] - One new foreign institution disclosed its holdings, BARCLAYS BANK PLC, while MORGAN STANLEY & CO. INTERNATIONAL PLC was not reported this quarter [1]